A PwC report indicates that AI is currently contributing to increased healthcare costs, primarily by enabling more detailed billing practices. This trend highlights AI's capability to enhance efficiency while simultaneously increasing financial burdens in the healthcare sector.

A survey by AXA and Ipsos across 18 countries reveals that 46% of respondents are struggling with mental health issues. More than 60% of people are turning to artificial intelligence for psychological support despite concerns about the negative impact of screens.

Pair Team has been accepted into the ACCESS program, a Medicare initiative aimed at testing AI-driven medical care. This program includes 150 participants selected by the Centers for Medicare & Medicaid Services.

Pennsylvania has filed a lawsuit against Character.AI for allowing chatbots to impersonate licensed doctors and provide psychological advice. The lawsuit claims that these chatbot personas misrepresent their qualifications, crossing into regulated medical practice.

Pennsylvania has filed a lawsuit against Character Technologies Inc., claiming its chatbots misrepresent themselves as licensed doctors. The lawsuit seeks to prevent the company from misleading users into believing they are receiving medical advice from qualified professionals.

AI systems are expected to assist in emergency rooms by providing faster diagnoses and supporting care teams in decision-making. Continuous monitoring of patients' vital signs and AI analysis of doctor-patient conversations will help identify potential errors in diagnoses.

Craig Venter, a key figure in the Human Genome Project, passed away on April 29th at the age of 79. He was known for his ambitious efforts to decode the human genome and was often seen as a rival to other prominent scientists in the field.

AISLE has identified 38 critical vulnerabilities (CVEs) in healthcare software utilized by 100,000 medical providers. The rapid digitization of healthcare is outpacing the implementation of adequate security measures.

OpenAI announced GPT-Rosalind, an AI model for life sciences, which significantly outperforms existing models in chemistry, biology, and experimental design. Similar to Anthropic's Claude Mythos and OpenAI's GPT-5.4-Cyber, GPT-Rosalind is initially restricted to qualified customers through a trusted access program.

Scientists created a fictitious disease and used AI to convince people of its existence. The experiment demonstrated AI's capability to influence public perception about health issues.